publication date: Feb. 2, 2018

Funding Opportunities AACR announces AACR-J&J lung cancer innovation science grants

The American Association for Cancer Research has launched the AACR-Johnson & Johnson Lung Cancer Innovation Science Grants.

A total of $4.5 million will be made available in research funding. Three multi-institutional research teams that seek novel approaches to the prevention, interception, and cure of lung cancer will each be awarded up to $1.5 million over three years.

The deadline for submission is March 2, at 1 p.m. EST. Research projects will begin on July 1, 2018.

Proposals should consider the concepts that lung cancer is often caused by behaviors that lead to: chronic exposure to respiratory carcinogens that produce cellular/genomic damage; chronic inflammation; alterations in innate and adaptive immunity; and changes in the pulmonary microbiome.

Consequently, these events may trigger the escape of transformed cells from immune surveillance. Proposals that characterize premalignant lesions or that substantially improve the detection of lung cancer at more curable stages will also be prioritized for funding.

Grant applications will be accepted from multi-institutional teams, composed of principal investigators from at least two, but no more than three, different institutions. The recipients will formally accept the grants at the AACR Annual Meeting April 14-18 in Chicago.

Applications must be submitted using the proposalCENTRAL website. Further details … Continue reading AACR announces AACR-J&J lung cancer innovation science grants

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.